Cedars-Sinai Medical Center - Archive stephen-freedland-870530
Filter by year
2026
May
26,
2026
|
06:00 AM
America/Los_Angeles
Physician-scientists from Cedars-Sinai Cancer and The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai, will present translational research designed to improve patient care and outcomes during the American Society of Clinical …
Read more
2025
November
04,
2025
|
09:00 AM
America/Los_Angeles
WebMD and Healthline recently interviewed Cedars-Sinai urologist Stephen Freedland, MD, about research he co-authored that found a new prostate cancer drug combination cut the risk of death by more than 40% in patients with advanced disease.The …
Read more
October
20,
2025
|
06:00 AM
America/Los_Angeles
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.The combination therapy, which adds a drug called enzalutamide to …
Read more
2024
June
26,
2024
|
08:00 AM
America/Los_Angeles
Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss …
Read more
March
04,
2024
|
09:00 AM
America/Los_Angeles
Verywell Health recently interviewed Stephen Freedland, MD, professor of Urology at Cedars-Sinai and director of the Center for Integrated Research in Cancer and Lifestyle at Cedars-Sinai Cancer, about the potential connection between rising rates …
Read more
2023
October
18,
2023
|
14:00 PM
America/Los_Angeles
Cedars-Sinai Cancer investigators have identified two promising new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard treatment. The results …
Read more
